{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T11:08:13Z","timestamp":1785928093000,"version":"3.56.0"},"reference-count":63,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100011198","name":"State Key Laboratory of Drug Research","doi-asserted-by":"publisher","award":["SKLDR-2022-LH-09"],"award-info":[{"award-number":["SKLDR-2022-LH-09"]}],"id":[{"id":"10.13039\/501100011198","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.ejmech.2025.117538","type":"journal-article","created":{"date-parts":[[2025,3,29]],"date-time":"2025-03-29T13:32:51Z","timestamp":1743255171000},"page":"117538","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Heterocycle-fused phenylcyclohexylamines as novel multi-target antagonists of N-methyl-D-aspartate (NMDA) receptor and monoamine transporter for treating depression"],"prefix":"10.1016","volume":"291","author":[{"given":"Fuqiang","family":"Zheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengtao","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hai","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaxin","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiongqiong","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiefang","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xudong","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nuriddinov","family":"Zayniddin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Safomuddin","family":"Abduahadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Obul","family":"Mamateli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pengcheng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianwen","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guanghui","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhijian","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiliang","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haji Akber","family":"Aisa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9679-9934","authenticated-orcid":false,"given":"Jingshan","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2025.117538_bib1","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.jpsychires.2019.08.002","article-title":"Changes in the global burden of depression from 1990 to 2017: findings from the global burden of disease study","volume":"126","author":"Liu","year":"2020","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.ejmech.2025.117538_bib2","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.1016\/S0140-6736(18)31948-2","article-title":"Depression","volume":"392","author":"Malhi","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.ejmech.2025.117538_bib3","series-title":"Stahl's Essential Psychopharmacology: Neuroscientific Basis and Practical Applications","author":"Stahl","year":"2021"},{"key":"10.1016\/j.ejmech.2025.117538_bib4","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1038\/s41380-022-01806-1","article-title":"Molecular pathways of major depressive disorder converge on the synapse","volume":"28","author":"Fries","year":"2023","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.ejmech.2025.117538_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2022.109378","article-title":"NMDA receptors as therapeutic targets for depression treatment: evidence from clinical to basic research","volume":"225","author":"Lv","year":"2023","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejmech.2025.117538_bib6","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1038\/nrd.2017.16","article-title":"Targeting glutamate signalling in depression: progress and prospects","volume":"16","author":"Murrough","year":"2017","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejmech.2025.117538_bib7","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1038\/nrn3504","article-title":"NMDA receptor subunit diversity: impact on receptor properties, synaptic plasticity and disease","volume":"14","author":"Paoletti","year":"2013","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.ejmech.2025.117538_bib8","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1124\/pr.109.002451","article-title":"Glutamate receptor ion channels: structure, regulation, and function","volume":"62","author":"Traynelis","year":"2010","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.ejmech.2025.117538_bib9","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/s41398-018-0162-2","article-title":"NMDA antagonists for treating the non-motor symptoms in Parkinson's disease","volume":"8","author":"Vanle","year":"2018","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.ejmech.2025.117538_bib10","doi-asserted-by":"crossref","first-page":"43","DOI":"10.3389\/fnins.2019.00043","article-title":"The role of NMDA receptors in alzheimer's disease","volume":"13","author":"Liu","year":"2019","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.ejmech.2025.117538_bib11","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.jphs.2016.10.002","article-title":"Human GRIN2B variants in neurodevelopmental disorders","volume":"132","author":"Hu","year":"2016","journal-title":"J. Pharmacol. Sci."},{"key":"10.1016\/j.ejmech.2025.117538_bib12","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.nurt.2009.07.008","article-title":"Targeting the NMDA receptor subunit NR2B for the treatment of neuropathic pain","volume":"6","author":"Wu","year":"2009","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.ejmech.2025.117538_bib13","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1038\/nn.2844","article-title":"Zinc alleviates pain through high-affinity binding to the NMDA receptor NR2A subunit","volume":"14","author":"Nozaki","year":"2011","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.ejmech.2025.117538_bib14","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/bs.apha.2016.01.006","article-title":"The NMDA receptor and schizophrenia: from pathophysiology to treatment","volume":"76","author":"Balu","year":"2016","journal-title":"Adv. Pharmacol."},{"key":"10.1016\/j.ejmech.2025.117538_bib15","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.3390\/ph17101265","article-title":"NMDA receptors: distribution, role, and insights into neuropsychiatric disorders","volume":"17","author":"Beaurain","year":"2024","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ejmech.2025.117538_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112242","article-title":"Identification of tetracyclic lactams as NMDA receptor antagonists with potential application in neurological disorders","volume":"194","author":"Espadinha","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117538_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112617","article-title":"Open and rearranged norbornane derived polycyclic cage molecules as potential neuroprotective agents through attenuation of MPP(+)- and calcium overload-induced excitotoxicity in neuroblastoma SH-SY5Y cells","volume":"204","author":"Egunlusi","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117538_bib18","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/S0028-3908(99)00019-2","article-title":"Memantine is a clinically well tolerated N-methyl-D-aspartate (NMDA) receptor antagonist\u2014a review of preclinical data","volume":"38","author":"Parsons","year":"1999","journal-title":"Neuropharmacol"},{"key":"10.1016\/j.ejmech.2025.117538_bib19","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1038\/mp.2013.130","article-title":"Lanicemine: a low-trapping NMDA channel blocker produces sustained antidepressant efficacy with minimal psychotomimetic adverse effects","volume":"19","author":"Sanacora","year":"2014","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.ejmech.2025.117538_bib20","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1038\/npp.2016.224","article-title":"Adjunctive lanicemine (AZD6765) in patients with major depressive disorder and history of inadequate response to antidepressants: a randomized, placebo-controlled study","volume":"42","author":"Sanacora","year":"2017","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.ejmech.2025.117538_bib21","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1517\/13543784.2014.852536","article-title":"GLYX-13, an NMDA receptor glycine site functional partial agonist enhances cognition and produces antidepressant effects without the psychotomimetic side effects of NMDA receptor antagonists","volume":"23","author":"Moskal","year":"2013","journal-title":"Expet Opin. Invest. Drugs"},{"key":"10.1016\/j.ejmech.2025.117538_bib22","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/S0960-894X(03)00007-6","article-title":"2-(3,4-Dihydro-1H-isoquinolin-2yl)-pyridines as a novel class of NR1\/2B subtype selective NMDA receptor antagonists","volume":"13","author":"Buttelmann","year":"2003","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2025.117538_bib23","doi-asserted-by":"crossref","DOI":"10.1002\/prp2.198","article-title":"Preclinical pharmacology and pharmacokinetics of CERC-301, a GluN2B-selective N-methyl-D-aspartate receptor antagonist","volume":"3","author":"Garner","year":"2015","journal-title":"Pharmacol. Res. Perspect."},{"key":"10.1016\/j.ejmech.2025.117538_bib24","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1080\/14737175.2019.1643237","article-title":"An update on NMDA antagonists in depression","volume":"19","author":"Pochwat","year":"2019","journal-title":"Expert Rev. Neurother."},{"key":"10.1016\/j.ejmech.2025.117538_bib25","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1080\/14728222.2016.1238899","article-title":"Ketamine's antidepressant action: beyond NMDA receptor inhibition","volume":"20","author":"Hashimoto","year":"2016","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.ejmech.2025.117538_bib26","doi-asserted-by":"crossref","first-page":"13514","DOI":"10.1021\/acs.jmedchem.0c01193","article-title":"Repurposing of drugs-the ketamine story","volume":"63","author":"Das","year":"2020","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117538_bib27","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1001\/archpsyc.63.8.856","article-title":"A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression","volume":"63","author":"Zarate","year":"2006","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.ejmech.2025.117538_bib28","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2021-067194","article-title":"Ketamine for the acute treatment of severe suicidal ideation: double blind, randomised placebo controlled trial","volume":"376","author":"Abbar","year":"2022","journal-title":"BMJ"},{"key":"10.1016\/j.ejmech.2025.117538_bib29","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1176\/appi.ajp.2017.17060647","article-title":"Ketamine for rapid reduction of suicidal thoughts in major depression: a midazolam-controlled randomized clinical trial","volume":"175","author":"Grunebaum","year":"2018","journal-title":"Am. J. Psychiatr."},{"key":"10.1016\/j.ejmech.2025.117538_bib30","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1176\/appi.ajp.2017.17040472","article-title":"The effect of a single dose of intravenous ketamine on suicidal ideation: a systematic review and individual participant data meta-analysis","volume":"175","author":"Wilkinson","year":"2018","journal-title":"Am. J. Psychiatr."},{"key":"10.1016\/j.ejmech.2025.117538_bib31","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1021\/acsmedchemlett.2c00055","article-title":"Fluoroalkylation of dextromethorphan improves CNS exposure and metabolic stability","volume":"13","author":"Sorrentino","year":"2022","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2025.117538_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.amsu.2022.104629","article-title":"Rapid-acting oral drug (Auvelity) for major depressive disorder","volume":"82","author":"Khabir","year":"2022","journal-title":"Ann. Med. Surg."},{"key":"10.1016\/j.ejmech.2025.117538_bib33","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1007\/s40263-024-01114-y","article-title":"Glutamatergic modulators for major depression from theory to clinical use","volume":"38","author":"McIntyre","year":"2024","journal-title":"CNS Drugs"},{"key":"10.1016\/j.ejmech.2025.117538_bib34","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1017\/S1461145712001496","article-title":"On 'polypharmacy' and multi-target agents, complementary strategies for improving the treatment of depression: a comparative appraisal","volume":"17","author":"Millan","year":"2014","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.ejmech.2025.117538_bib35","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1017\/S0033291715002159","article-title":"Single i.v. ketamine augmentation of newly initiated escitalopram for major depression: results from a randomized, placebo-controlled 4-week study","volume":"46","author":"Hu","year":"2016","journal-title":"Psychol. Med."},{"key":"10.1016\/j.ejmech.2025.117538_bib36","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.jad.2018.02.056","article-title":"Does oral administration of ketamine accelerate response to treatment in major depressive disorder? Results of a double-blind controlled trial","volume":"235","author":"Arabzadeh","year":"2018","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.ejmech.2025.117538_bib37","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1093\/ijnp\/pyz039","article-title":"Efficacy and safety of fixed-dose esketamine nasal spray combined with a new oral antidepressant in treatment-resistant depression: results of a randomized, double-blind, active-controlled study (transform-1)","volume":"22","author":"Fedgchin","year":"2019","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.ejmech.2025.117538_bib38","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1080\/14656566.2019.1683161","article-title":"Efficacy and safety of intranasal esketamine for the treatment of major depressive disorder","volume":"21","author":"Kryst","year":"2020","journal-title":"Expet Opin. Pharmacother."},{"key":"10.1016\/j.ejmech.2025.117538_bib39","first-page":"9","article-title":"The importance of norepinephrine in depression","volume":"7","author":"Moret","year":"2011","journal-title":"Neuropsychiatric Dis. Treat."},{"key":"10.1016\/j.ejmech.2025.117538_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2024.116564","article-title":"Synthesis and biological evaluation of multimodal monoaminergic arylpiperazine derivatives with potential antidepressant profile","volume":"275","author":"Zheng","year":"2024","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117538_bib41","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1021\/cn100008c","article-title":"Moving beyond rules: the development of a central nervous system multiparameter optimization (CNS MPO) approach to enable alignment of druglike properties","volume":"1","author":"Wager","year":"2010","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.ejmech.2025.117538_bib42","doi-asserted-by":"crossref","first-page":"9824","DOI":"10.1021\/acs.jmedchem.9b01220","article-title":"The blood-brain barrier (BBB) score","volume":"62","author":"Gupta","year":"2019","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117538_bib43","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/nature12648","article-title":"Structural basis for action by diverse antidepressants on biogenic amine transporters","volume":"503","author":"Wang","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2025.117538_bib44","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.sbi.2019.03.011","article-title":"Insights into the mechanism and pharmacology of neurotransmitter sodium symporters","volume":"54","author":"Navratna","year":"2019","journal-title":"Curr. Opin. Struct. Biol."},{"key":"10.1016\/j.ejmech.2025.117538_bib45","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.56427","article-title":"Chemical and structural investigation of the paroxetine-human serotonin transporter complex","volume":"9","author":"Coleman","year":"2020","journal-title":"Elife"},{"key":"10.1016\/j.ejmech.2025.117538_bib46","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1038\/s41586-024-07638-z","article-title":"Transport and inhibition mechanisms of the human noradrenaline transporter","volume":"632","author":"Hu","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2025.117538_bib47","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1038\/s41586-024-07739-9","article-title":"Structure of the human dopamine transporter and mechanisms of inhibition","volume":"632","author":"Srivastava","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2025.117538_bib48","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1038\/s41586-024-07804-3","article-title":"Structure of the human dopamine transporter in complex with cocaine","volume":"632","author":"Nielsen","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2025.117538_bib49","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1038\/s41422-024-01024-0","article-title":"Mechanistic insights of substrate transport and inhibitor binding revealed by high-resolution structures of human norepinephrine transporter","volume":"34","author":"Song","year":"2024","journal-title":"Cell Res."},{"key":"10.1016\/j.ejmech.2025.117538_bib50","doi-asserted-by":"crossref","first-page":"5455","DOI":"10.1016\/j.tetlet.2005.06.066","article-title":"1,2,3-Triazole as a safer and practical substitute for cyanide in the Bruylants reaction for the synthesis of tertiary amines containing tertiary alkyl or aryl groups","volume":"46","author":"Prashad","year":"2005","journal-title":"Tetrahedron Lett."},{"key":"10.1016\/j.ejmech.2025.117538_bib51","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1021\/ml200030q","article-title":"Discovery of INCB3284, a potent, selective, and orally bioavailable hCCR2 antagonist","volume":"2","author":"Xue","year":"2011","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2025.117538_bib52","doi-asserted-by":"crossref","first-page":"4572","DOI":"10.1021\/acs.orglett.7b02177","article-title":"Synthesis and N-Methyl-d-aspartate (NMDA) receptor activity of ketamine metabolites","volume":"19","author":"Morris","year":"2017","journal-title":"Org. Lett."},{"key":"10.1016\/j.ejmech.2025.117538_bib53","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1021\/acsmedchemlett.1c00326","article-title":"Optimization of triarylpyridinone inhibitors of the main protease of SARS-CoV-2 to low-nanomolar antiviral potency","volume":"12","author":"Zhang","year":"2021","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2025.117538_bib54","doi-asserted-by":"crossref","first-page":"3005","DOI":"10.1021\/jm701524h","article-title":"Bioisosteric heterocyclic versions of 7-{[2-(4-Phenyl-piperazin-1-yl)ethyl]propylamino}-5,6,7,8-tetrahydronaphthalen-2-ol: identification of highly potent and selective agonists for dopamine D3 receptor with potent in vivo activity","volume":"51","author":"Biswas","year":"2008","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117538_bib55","doi-asserted-by":"crossref","first-page":"11685","DOI":"10.1039\/D2NJ01962K","article-title":"Neat synthesis of isothiazole compounds, and studies on their synthetic applications and photophysical properties","volume":"46","author":"Bera","year":"2022","journal-title":"New J. Chem."},{"key":"10.1016\/j.ejmech.2025.117538_bib56","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1016\/j.tetlet.2016.01.055","article-title":"Base catalyzed reaction of ethyl thioglycolate with \u03b2-aryl-\u03b2-(methylthio) acroleins: a general method for the synthesis of 2-carbethoxy-5-substituted\/4,5-annulated thiophenes in high overall yields","volume":"57","author":"Byre Gowda","year":"2016","journal-title":"Tetrahedron Lett."},{"key":"10.1016\/j.ejmech.2025.117538_bib57","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.ejmech.2008.03.006","article-title":"Synthesis, cytotoxicity and effects of some 1,2,4-triazole and 1,3,4-thiadiazole derivatives on immunocompetent cells","volume":"44","author":"Mavrova","year":"2009","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117538_bib58","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1021\/acs.oprd.5b00027","article-title":"An improved synthesis of 4-(1-piperazinyl)benzo[b]thiophene dihydrochloride","volume":"19","author":"Wu","year":"2015","journal-title":"Org. Process Res. Dev."},{"key":"10.1016\/j.ejmech.2025.117538_bib59","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/0014-5793(85)81313-2","article-title":"Differentiation of [3H]phencyclidine and (+)-[3H]SKF-10,047 binding sites in rat cerebral cortex","volume":"190","author":"Goldman","year":"1985","journal-title":"FEBS Lett."},{"key":"10.1016\/j.ejmech.2025.117538_bib60","doi-asserted-by":"crossref","first-page":"2584","DOI":"10.1021\/jm501535r","article-title":"CNS drug design: balancing physicochemical properties for optimal brain exposure","volume":"58","author":"Rankovic","year":"2015","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117538_bib61","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2025.117349","article-title":"D-morphinan analogs with favorable pharmacokinetic profiles as dual-acting antidepressants","volume":"287","author":"Ji","year":"2025","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117538_bib62","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.bbr.2018.07.004","article-title":"Low-frequency repetitive transcranial magnetic stimulation inhibits the development of methamphetamine-induced conditioned place preference","volume":"353","author":"Wu","year":"2018","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.ejmech.2025.117538_bib63","article-title":"Generic Diagramming Platform (GDP): a comprehensive database of high-quality biomedical graphics","author":"Jiang","year":"2024","journal-title":"Nucleic Acids Res."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523425003034?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523425003034?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T04:49:11Z","timestamp":1778042951000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523425003034"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":63,"alternative-id":["S0223523425003034"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2025.117538","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Heterocycle-fused phenylcyclohexylamines as novel multi-target antagonists of N-methyl-D-aspartate (NMDA) receptor and monoamine transporter for treating depression","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2025.117538","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"117538"}}